Navigation Links
Wrinkle Fillers Need Better Label Warnings: FDA Panel

Reports of allergic reactions, other problems have surfaced with these products, experts say

TUESDAY, Nov. 18 (HealthDay News) - American women who turn to cosmetic treatments called dermal fillers to ease wrinkles must be better informed as to the health risks these products pose, an advisory panel to the U.S. Food and Drug Administration recommended Tuesday.

The panel of independent experts urged the agency to revise product labeling to warn of potential reactions to the fillers, including bumps, blotching and scarring.

While side effects are relatively rare, the U.S. Food and Drug Administration has also received reports of allergic reactions, including some that were life-threatening, such as anaphylactic shock, the agency said.

"The labeling should be modified to reflect what we're learning further about the products'' in various post-marketing studies and elsewhere, panel member Mary McGrath, a professor of surgery at the University of California in San Francisco, told Bloomberg News.

According to the American Society for Aesthetic Plastic Surgery, nearly 1,449,000 procedures involving fillers were performed in the United States last year.

The FDA is not bound to follow the recommendations of its advisory panels, although it typically does so. As part of their review, the group reviewed a variety of reports to see if stronger warning labels were needed for the injectable products. Some fillers are made from natural substances, while others come from synthetic materials. Brand names for some of these products include Restylane, Juvederm, Artefill, and Perlane.

The FDA has also asked the panel to make recommendations on testing the dermal fillers, post-approval follow-up and informing consumers about potential risks. The meeting was spurred by reports of 823 injuries caused by dermal fillers that included allergic reactions, swelling, sores, pain, blisters and cysts.

Overall, 638 patients needed additional medical treatment. Nineteen patients were seen in emergency rooms with life-threatening allergic reactions, such as difficulty breathing. Twelve patients had to be admitted to hospitals due to infections, the FDA said.

Medications used to treat problems ranged from topical steroid creams to multiple courses of oral antibiotics, topical steroids, anti-inflammatory or antihistamine drugs, and intra-lesion steroid injections. Ninety-four of the 823 reported injuries required surgical intervention, ranging from opening an abscess for drainage of pus, to biopsy of lesions, the FDA said.

One of the FDA's concerns is that some of the products are being used in ways that they weren't approved for -- called "off-label use."

"The trouble is that once this material is in the hands of physicians, there's really not much control over how it's used and where it's placed," Dr. Scott Spear, a Washington plastic surgeon., told the AP. "That creates the potential for a certain amount of mischief."

There's limited data on how darker-skinned people may react to the dermal filler treatments. Hispanic, black and Asian patients may develop blotches and other complications, the FDA said.

"Off-label" use of these products may be the cause of some of these problems. Lip enhancement is a common off-label use, the FDA said.

Another concern is what happens to the fillers as they break down and circulate throughout the body. Most of the products appear to cause no problems, but one contains small plastic balls that aren't absorbed by the body, the FDA has noted.

More information

For more on cosmetic surgery, visit the American Society of Plastic Surgeons.

SOURCE: U.S. Food and Drug Administration; Nov. 18, 2008, Associated Press, Bloomberg News

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Cougars Crave Biocap, The Haute Pepper Wrinkle Eraser
2. New Study Provides Scientific Evidence That DermaLastyl Face Cream Reduces Wrinkles
3. Botox Cosmetic Alternatives Are Available: Surgical Procedures Offer Solution for Wrinkles
4. FDA Grants Over-The-Counter Clearance to GentleWaves(R) for the First Home Use Light-Based Device to Treat Wrinkles
5. GFX: Wrinkle-Killer or Botox(R) Hit-Man?
6. Grassini & Wrinkle Law Firm Are Awarded Largest PI Verdict in Ventura County History
7. New Medical Technology is Changing the Face of Wrinkle Treatment
8. Another new wrinkle in treating skin aging
9. Clinical Trial Concluded For New Wrinkle Treatment
10. FDA Takes Closer Look at Wrinkle Treatments
11. Dr. Arnold Klein Warns of Dangers With Permanent and Longer Lasting Injectable Fillers
Post Your Comments:
Related Image:
Wrinkle Fillers Need Better Label Warnings: FDA Panel
(Date:12/1/2015)... ... December 01, 2015 , ... XTC Semifinals 2016 ... semi-finalists to head to Las Vegas for CES 2016, the world’s largest Consumer Electronic ... Consumer Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica Serra, and venture ...
(Date:12/1/2015)... ... ... With FCPX Overlay: Grit , users can apply a grit effect ... truly endless, all with a click of a mouse. Each user has full control ... of field and more, all within Final Cut Pro X. , With FCPX Overlay: ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Magazine as a Modern Man for 2015. , Angeleno Magazine is a ... United States. Established in 1994, Modern Luxury includes more than 50 magazine titles ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes Tympani as ... Cisco Unified Contact Center solutions targeted to the high-end enterprise contact center marketplace. ...
(Date:11/30/2015)... ... November 30, 2015 , ... Olympic Gold Medalists ... collaborating with brands across various categories through traditional and social media marketing campaigns ... elite group of Gold Medal Moms who can connect with today’s most important ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015  The migration ... to develop shared care plans that help patients ... care plans will be digitally enabled, incorporate care ... needs and desires. They will also allow all ... patient,s health journey is optimal. That is the ...
(Date:12/1/2015)... , December 1, 2015 ... of eye and gaze tracking solutions, today announced that ... trackers as a component of its revolutionary new vision ... and medical and performance issues in patients. The new ... mass-market-ready eye tracking platform, which is ready to be ...
(Date:12/1/2015)... Dec. 1, 2015  Lexicon Pharmaceuticals, Inc. ... top-line data from its TELECAST Phase 3 ... treating carcinoid syndrome in cancer patients with ... benefit observed in its pivotal TELESTAR study.  ... companion to TELESTAR primarily to provide additional ...
Breaking Medicine Technology: